Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002616

Options or other derivatives

  • Director acquired 3,334 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Walts Alan Edmund Director 2021-05-19 Grant or award · Stock Option (Right to Buy) +3,334 3,334 D: show line 1 in the form
Loading xslF345X03/form4-05202021_040547.xml…